ARTICLE | Clinical News
Visudyne verteporfin for injection regulatory update
August 27, 2001 7:00 AM UTC
QLT and partner Novartis Ophthalmics (Bulach, Switzerland) received FDA approval for Visudyne verteporfin injection to treat predominantly classic subfoveal choroidal neovascularization (CNV) caused b...